Watson Pharmaceuticals Reports Third Quarter 20...( Total Net Revenue of $641 Million;...),Health
Navigation Links
Watson Pharmaceuticals Reports Third Quarter 2008 Results
Date:10/29/2008
Total Net Revenue of $641 Million; GAAP EPS $0.62; Adjusted EPS $0.47
CORONA, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2008.
Third Quarter 2008 Results
Net revenue for the third quarter 2008 increased $46.0 million or 8 percent from the third quarter 2007 to $640.7 million, and net income was $71.1 million, or $0.62 per diluted share. Excluding special items as detailed in the reconciliation table below, adjusted net income for the third quarter was $53.9 million, or $0.47 per diluted share. Adjusted EBITDA for the third quarter 2008 was $137.2 million and cash flow from operations was $74.0 million. Cash and marketable securities were $352.0 million as of September 30, 2008.
"This has been a positive quarter for Watson, and one that continues to demonstrate the strength and financial health of the Company," began Paul Bisaro, Watson's President and Chief Executive Officer. "Importantly, our performance strength was spread across all of our divisions. The launch of omeprazole 40mg contributed to solid results in our Generics division and two new product launches contributed to a strong performance in our Anda distribution division."
"By far, the biggest news we had this quarter was the approval of
RAPAFLO(TM) (silodosin), our new alpha blocker for BPH," continued Mr.
Bisaro. "RAPAFLO is the first of three new brand products we expect to
introduce in 2009 and will help strengthen the foundation for our future
growth in the Urology specialty area. We are committed to achieving strong
performances in all of our businesses and remain very optimistic i
'/>"/>
| SOURCE Watson Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
(Date:12/5/2009)... experts advise , , SATURDAY, Dec. 5 (HealthDay News) -- ... can have bad reactions to certain holiday traditions and ... wheezing, according to the American College of Allergy, Asthma ... live evergreens may choose to decorate with artificial plants, ...
(Date:12/5/2009)... their cleaning processes. The technology available to the lab allows it ... customers relating to cleaning parts, process development, and verification. , ... ... a Jackson, MI-based company, is home to an advanced technology center ...
(Date:12/5/2009)... is a collaborative effort by the National Association ... North America (MANA), Citizens for Midwifery (CfM), International ... of Midwives (NARM), and the Midwifery Education Accreditation ... efforts of The MAMA Campaign to secure federal ...
(Date:12/4/2009)... Dec. 4 Varian Medical Systems (NYSE: VAR ... the regular 2010 Annual Meeting of Stockholders for February 11, ... meeting will be held at the Crowne Plaza Cabana Hotel, ... PT. ,, The meeting will be webcast by Thomson Financial ...
(Date:12/4/2009)... 4 Thousands of KPMG LLP employees came together in ... community service event which combines the audit, tax and advisory ... national service day reflects our firm,s long history of volunteerism. ... of caring to brighten the holidays for some children," said ...
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2[0] Keep Asthma, Allergies at Bay for the Holidays[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification[0] AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign [0] Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto[0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children
... characteristics help fine-tune treatment, study says , , FRIDAY, Dec. ... predicting breast cancer risk, recurrence risk and response to ... density and tumor size, a panel of experts report. ... Friday at the annual San Antonio Breast Cancer Symposium ...
... [The Washington Post Friday reported that the ... the White House are considering easing the official advisory cautioning ... at the Environmental Protection Agency reportedly are concerned about the ... of several "midnight" rules and policy changes in the pipeline ...
... Dec. 12 Roberta Kalafut, D.O., just announced her resignation ... a close the worst abuses of power by the TMB ... disciplinary actions, particularly against her competitors, and stonewalling by the ... "We applaud Kalafut,s resignation," said AAPS Executive Director ...
... climes becoming more conducive to spread , , FRIDAY, Dec. ... risk for infection with so-called "airport malaria" in malaria-free ... , Here,s how it happens, as the scientists explain ... tropical regions, and at the end of a flight ...
... to consumer-directed plan , , ... to make the most of their money, particularly their health ... 2.0, which helps members manage costs and still keep the ... a high-deductible plan with a health savings account (HSA). This ...
... , SAN ANTONIO, TEXAS - Early-stage breast cancer patients ... significant risk of recurrence of their disease, compared to those ... according to a study led by researchers at The University ... presented today at the CRTC-AACR San Antonio Breast Cancer Symposium, ...
Other Medicine News:Health News:Progress Made in Predicting Breast Cancer Risk 2Health News:Progress Made in Predicting Breast Cancer Risk 3Health News:AAPS Applauds the Resignation of TMB President Roberta Kalafut, Mari Robinson Should Resign Next 2Health News:'Airport Malaria' Risk Rising With Global Warming 2Health News:'Airport Malaria' Risk Rising With Global Warming 3Health News:Regence Unveils New Approach to Healthcare With Launch of HSA Healthplan 2.0 2Health News:Early stage, HER2-positive breast cancer patients at increased risk of recurrence 2Health News:Early stage, HER2-positive breast cancer patients at increased risk of recurrence 3Progress Made in Predicting Breast Cancer RiskLeahy Slams 'Midnight' Bid to Relax Mercury-in-Fish Warnings to Women and ChildrenAAPS Applauds the Resignation of TMB President Roberta Kalafut, Mari Robinson Should Resign Next'Airport Malaria' Risk Rising With Global WarmingRegence Unveils New Approach to Healthcare With Launch of HSA Healthplan 2.0Early stage, HER2-positive breast cancer patients at increased risk of recurrence
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...
(Date:12/4/2009)... Shore and E. David Crawford presented results for prostate-specific ... end points of biochemical recurrence rate in a Phase ... or monthly leuprolide in prostate cancer patients during the ... received FIRMAGON 240/80 mg/month had a recurrence rate of ...
(Date:12/3/2009)... ACTON, Mass., Dec. 3 Allen Medical Systems, a ... ), today announced the launch of its new Allen ... www.AllenAmatech.com . ,, The website reinforces the ... of the new product catalog, with detailed descriptions and ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2EHE International Supports the National Headache Foundation 48180 1EHE International Supports the National Headache Foundation 48180 2Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 1Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 2Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany 48177 1Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany 48177 2Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany 48177 3[0] Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer[0] Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial[0] Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website
... Complete Remission / Unconfirmed Complete Remission Rate 3.5 Fold Higher ... Compared to ... (Nasdaq and MTA: CTIC) announced today that it achieved the ... pixantrone,(BBR2778) for patients with advanced, relapsed aggressive non-Hodgkin,s,lymphoma (NHL) based ...
... Demonstrate Test,s Potential for ... Rapid Uptake, ... Applied Biosystems Inc. (NYSE: ABI ) today,announced the launch of BCtect(TM), ... a unique gene expression signature,identified by DiaGenic using a custom TaqMan(R) Array ...
Other Medicine Technology:Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 2Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 3Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 4Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test 2Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |